Cohen Milstein Sellers & Toll PLLC Announces the Investigation of ... DailyFinance The complaints allege that Peregrine and certain of its officers and directors ("Defendants") misrepresented and/or failed to disclose that: (1) the clinical data from the Company's Phase II trial of bavituximab, one of Peregrine's lead product ...
No comments:
Post a Comment